HOG
30
4
EL
33
3
STI
1
-12
EFX
38
3
AMT
28
4
CNP
54
8
MAT
58
-5
L
45
2
GILD
38
-11
CVS
48
8
DG
2
-14
DVA
66
5
LEG
33
5
O
20
-8
T
29
-4
HSY
32
-2
IP
48
-2
KMB
30
2
DHR
49
3
FSLR
49
-3
HOG
30
4
EL
33
3
STI
1
-12
EFX
38
3
AMT
28
4
CNP
54
8
MAT
58
-5
L
45
2
GILD
38
-11
CVS
48
8
DG
2
-14
DVA
66
5
LEG
33
5
O
20
-8
T
29
-4
HSY
32
-2
IP
48
-2
KMB
30
2
DHR
49
3
FSLR
49
-3
Financhill
Back

Cassava Sciences Vs. Blueprint Medicines Industry Stock Comparison

Sell
31

SAVA
Cassava Sciences

Last Price:
$2.62
Seasonality Move:
20.94%
Sell
40

BPMC
Blueprint Medicines

Last Price:
$102.47
Seasonality Move:
5.27%
Sell
31
Cassava Sciences (SAVA) is a Sell

Is Cassava Sciences a Buy, Sell or Hold?

  • The current Cassava Sciences [SAVA] share price is $2.61. The Score for SAVA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • SAVA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $102.56. The Score for BPMC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SAVA Stock Price Chart

What is Cassava Sciences's stock price today?

  • The Cassava Sciences share price today is $2.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing selling pressure, which indicates risk of future bearish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $102.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing selling pressure, which indicates risk of future bearish movement.

SAVA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.84 Sell
Relative Strength Index (14 RSI): 28.35 Sell
Chaikin Money Flow: -1179246 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.44 - 2.92) Sell
Bollinger Bands (100): (7.78 - 31.42) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.85 Buy
Relative Strength Index (14 RSI): 63.82 Buy
Chaikin Money Flow: -913925 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.06 - 96.6) Buy
Bollinger Bands (100): (86.99 - 95.95) Buy

SAVA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.82 Sell
20-day SMA: 2.61 Sell
50-day SMA: 10.97 Sell
200-day SMA: 19.8 Sell
8-day EMA: 2.74 Sell
20-day EMA: 3.63 Sell
50-day EMA: 9.22 Sell
200-day EMA: 18.23 Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 92.93 Buy
20-day SMA: 91.76 Buy
50-day SMA: 93.83 Buy
200-day SMA: 96.87 Buy
8-day EMA: 94.89 Buy
20-day EMA: 92.92 Buy
50-day EMA: 92.72 Buy
200-day EMA: 91.71 Buy

Cassava Sciences Earnings Growth & SAVA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.37 per share, and a decrease next year of $0.88 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.

Cassava Sciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):